Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$74.84 - $88.15 $47,224 - $55,622
631 Added 17.73%
4,189 $348,000
Q4 2023

Feb 06, 2024

BUY
$69.57 - $78.12 $27,967 - $31,404
402 Added 12.74%
3,558 $277,000
Q3 2023

Nov 03, 2023

BUY
$76.74 - $85.2 $11,204 - $12,439
146 Added 4.85%
3,156 $243,000
Q2 2023

Aug 04, 2023

SELL
$69.16 - $82.11 $5,532 - $6,568
-80 Reduced 2.59%
3,010 $247,000
Q1 2023

May 01, 2023

BUY
$64.46 - $77.23 $199,181 - $238,640
3,090 New
3,090 $217,000
Q3 2022

Nov 03, 2022

BUY
$56.96 - $78.09 $48,529 - $66,532
852 Added 28.01%
3,894 $226,000
Q2 2022

Aug 02, 2022

BUY
$64.25 - $81.25 $21,973 - $27,787
342 Added 12.67%
3,042 $213,000
Q1 2022

May 09, 2022

BUY
$71.65 - $87.13 $193,455 - $235,251
2,700 New
2,700 $214,000

Others Institutions Holding ALC

About ALCON INC


  • Ticker ALC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 490,087,008
  • Market Cap $41B
  • Description
  • Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...
More about ALC
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.